Equity · Healthcare
ESPR
Esperion Therapeutics, Inc. · NasdaqGM
The line runs $3.13 on 21 May through $3.19 on 10 July, on a scale from $3.100 to $3.200. Days the market did not trade hold the previous close, flat.
The chart above plots the price of ESPR over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 34 sessions over that window: $3.13 on 21 May 2026 through $3.19 on 10 July 2026.
Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 19, 2026
ESPR insider trades
Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Showing the 12 most recent of 14 compensation filings in this window. The figures above count all of them.
ESPR earnings
no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
ESPR institutional holders
8 of the 45 institutional funds we track reported a ESPR position for the quarter ended 30 Jun 2026 — a combined $49.2M; the latest of those filings landed 14 Aug 2026.
Source: SEC EDGAR 13F filings
ESPR fails-to-deliver
On 09 Jul 2026, 43,283 shares of ESPR failed to deliver (about $138K) — the latest of at least 4 consecutive trading days with recorded fails. The run reaches the start of the window we read, so it may have begun earlier.
Source: SEC fails-to-deliver (CNS) data